India is ranked 3rd worldwide in the production of pharmaceutical products by volume and 14th by value.
India is the largest provider of generic medicines globally, occupying a 20 per cent share in global supply by volume.
India is the leading vaccine manufacturer globally with a market share of 60 per cent.
Homemade canned, preserved or fermented foodstuffs are a common source of foodborne botulism and their preparation requires extra caution.
Buruli ulcer often affects the skin and sometimes bone and can lead to permanent disfigurement and long-term disability. The mode of transmission is not known and there is no prevention for the disease.
Young adolescents aged 10 - 14 years have the lowest risk of death of all age groups.
Beyond health consequences, the harmful use of alcohol brings significant social and economic losses to individuals and society at large.
The most common cancers globally are breast, lung, colon and rectum and prostate cancers.
Over three quarters of CVD deaths take place in low- and middle-income countries. (CVD = Cardiovascular disease).
The most common types of childhood cancers include leukemias, brain cancers, lymphomas and solid tumours, such as neuroblastoma and Wilms tumours.
Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC). (COPD = Chronic Obstructive Pulmonary Disease).
India, which is home to about 16 per cent of the world's women, accounts for about a quarter of all cervical cancer incidences and nearly a third of global cervical cancer deaths.
Climate change affects the social and environmental determinants of health – clean air, safe drinking water, sufficient food and secure shelter.
Over 1 billion young adults are at risk of permanent, avoidable hearing loss due to unsafe listening practices.
As per the USFDA, a class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".
Indian women face a 1.6 per cent lifetime cumulative risk of developing cervical cancer and a one per cent cumulative death risk from cervical cancer.
Recent estimates state that every year almost 80,000 women develop cervical cancer and 35,000 die in India due to it.
Globally, the market for laboratory products is estimated at Rs 24,000 crore and dominated by a few developed countries.